EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Autoimmune astrocytopathy double negative for AQP4‐IgG and GFAP‐IgG: Retrospective research of clinical practice, biomarkers, and pathology

Pei-Hao Lin, Hai-Yan Yao, Li Huang, Cong-Cong Fu, Xiao-Li Yao, Chun Lian, Shi-Feng Zhang, Wen-Dong Lai, Guan-Yan Lin, Sha Liao, Jie Yang, Zhi-Feng Mao und 5 weitere

CNS Neuroscience & Therapeutics · 2024-09 · 30 (9)

DOI: 10.1111/cns.70042 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 15.09.2024. Verfasst von Pei-Hao Lin und 16 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province, Department of Neurology, Institute of Neuroscience, Ministry of Education …. Hauptthemen laut MEDLINE: Glial Fibrillary Acidic Protein, Aquaporin 4, Astrocytes, Biomarkers. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, Multi-center Project of The Second Affiliated Hospital of Guangzhou Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The objective of this study is to investigate the presence of astrocyte antibodies in patients, excluding aquaporin‐4 or glial fibrillary acidic protein (GFAP) antibodies, while evaluating associated biomarkers and pathologies.

Methods

Patient serum and cerebrospinal fluid (CSF) were tested for antibodies using tissue‐ and cell‐based assays. Neurofilament light chain (NFL) and GFAP in the CSF were detected using single‐molecule array (SIMOA).

Results

116 patients accepted SIMOA. Fifteen functional neurological disorders patients without antibodies were designated as controls. Thirty‐five patients were positive for astrocyte antibodies (Anti‐GFAP: 7; Anti‐AQP4: 7; unknown antibodies: 21, designed as the double‐negative group, DNAP). The most frequent phenotype of DNAP was encephalitis (42.9%), followed by myelitis (23.8%), movement disorders (19.0%), and amyotrophic lateral sclerosis‐like (ALS‐like) disease (14.2%). The levels of CSF GFAP and NFL in DNAP were higher than in the control (GFAP: 1967.29 [776.60–13214.47] vs 475.38 [16.80–943.60] pg/mL, p < 0.001; NFL: 549.11 [162.08–2462.61] vs 214.18 [81.60–349.60] pg/mL, p = 0.002). GFAP levels decreased in DNAP ( n = 5) after immunotherapy (2446.75 [1583.45–6277.33] vs 1380.46 [272.16–2005.80] pg/mL, p = 0.043), while there was no difference in NFL levels (2273.78 [162.08–2462.61] vs 890.42 [645.06–3168.06] pg/mL, p = 0.893). Two brain biopsy patterns were observed: one exhibited prominent tissue proliferation and hypertrophic astrocytes, with local loss of astrocytes, while the other showed severe astrocyte depletion with loss of neurofilaments around the vessels. Eighteen patients received immunotherapy, and improved except one with ALS‐like symptoms. We identified anti‐vimentin in this patient.

Discussion

There are unidentified astrocyte antibodies. The manifestations of double‐negativity are heterogeneous; nevertheless, the pathology and biomarkers remain consistent with astrocytopathy. Immunotherapy is effective.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glial Fibrillary Acidic ProteinAquaporin 4AstrocytesBiomarkersImmunoglobulin GHumansFemaleMaleMiddle AgedRetrospective StudiesAdultAgedNeurofilament ProteinsAutoantibodiesYoung AdultAdolescent

Stichwörter der Autor:innen

autoimmune astrocytopathyautoimmune encephalitisglial fibrillary acidic proteinneurofilament light chain

Substanzen

Glial Fibrillary Acidic ProteinAquaporin 4GFAP protein, humanBiomarkersImmunoglobulin GAQP4 protein, humanNeurofilament ProteinsAutoantibodiesneurofilament protein L

Autor:innen und Institutionen

  • Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province, Department of Neurology, Institute of Neuroscience, Ministry of Education of China, The Second Affiliated Hospital, Guangzhou Medical University…
  • Department of Neurology, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China.
  • Department of Neurology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Institution of Kingmed, Guangzhou Medical University, Guangzhou, China.
  • Department of Neurology, The Third Xiangya Hospital of Central South University, Changsha, China.
  • The First Clinical College, Changsha Medical University, Changsha, China.

ORCID-Profile: You-Ming Long

Förderung

  • Basic and Applied Basic Research Foundation of Guangdong Province
  • Multi-center Project of The Second Affiliated Hospital of Guangzhou Medical University

Zitieren

APA

Lin, P. H., Yao, H. Y., Huang, L., Fu, C. C., Yao, X. L., Lian, C., Zhang, S. F., Lai, W. D., Lin, G. Y., Liao, S., Yang, J., Mao, Z. F., Liu, D., Long, B. Y., Yue, J. J., Gao, C., & Long, Y. M. (2024). Autoimmune astrocytopathy double negative for AQP4‐IgG and GFAP‐IgG: Retrospective research of clinical practice, biomarkers, and pathology. CNS Neuroscience & Therapeutics, 30(9). https://doi.org/10.1111/cns.70042

Vancouver

Lin PH, Yao HY, Huang L, Fu CC, Yao XL, Lian C, et al. Autoimmune astrocytopathy double negative for AQP4‐IgG and GFAP‐IgG: Retrospective research of clinical practice, biomarkers, and pathology. CNS Neuroscience & Therapeutics. 2024;30(9). doi:10.1111/cns.70042

BibTeX
@article{Lin2024,
  author = {Lin, Pei-Hao and Yao, Hai-Yan and Huang, Li and Fu, Cong-Cong and Yao, Xiao-Li and Lian, Chun and Zhang, Shi-Feng and Lai, Wen-Dong and Lin, Guan-Yan and Liao, Sha and Yang, Jie and Mao, Zhi-Feng and Liu, Ding and Long, Bao-Yi and Yue, Jia-Jia and Gao, Cong and Long, You-Ming},
  title = {Autoimmune astrocytopathy double negative for AQP4‐IgG and GFAP‐IgG: Retrospective research of clinical practice, biomarkers, and pathology},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2024},
  volume = {30},
  number = {9},
  doi = {10.1111/cns.70042}
}
Kostenlos starten →